366 related articles for article (PubMed ID: 8107717)
1. X-linked pyridoxine-responsive sideroblastic anemia due to a Thr388-to-Ser substitution in erythroid 5-aminolevulinate synthase.
Cox TC; Bottomley SS; Wiley JS; Bawden MJ; Matthews CS; May BK
N Engl J Med; 1994 Mar; 330(10):675-9. PubMed ID: 8107717
[TBL] [Abstract][Full Text] [Related]
2. New mutation in erythroid-specific delta-aminolevulinate synthase as the cause of X-linked sideroblastic anemia responsive to pyridoxine.
Kucerova J; Horvathova M; Mojzikova R; Belohlavkova P; Cermak J; Divoky V
Acta Haematol; 2011; 125(4):193-7. PubMed ID: 21252495
[TBL] [Abstract][Full Text] [Related]
3. Late-onset X-linked sideroblastic anemia. Missense mutations in the erythroid delta-aminolevulinate synthase (ALAS2) gene in two pyridoxine-responsive patients initially diagnosed with acquired refractory anemia and ringed sideroblasts.
Cotter PD; May A; Fitzsimons EJ; Houston T; Woodcock BE; al-Sabah AI; Wong L; Bishop DF
J Clin Invest; 1995 Oct; 96(4):2090-6. PubMed ID: 7560104
[TBL] [Abstract][Full Text] [Related]
4. The molecular biology and pyridoxine responsiveness of X-linked sideroblastic anaemia.
May A; Bishop DF
Haematologica; 1998 Jan; 83(1):56-70. PubMed ID: 9542324
[TBL] [Abstract][Full Text] [Related]
5. Erythroid 5-aminolevulinate synthase and X-linked sideroblastic anemia.
Ferreira GC
J Fla Med Assoc; 1993 Jul; 80(7):481-3. PubMed ID: 8089650
[TBL] [Abstract][Full Text] [Related]
6. X-linked sideroblastic anemia: identification of the mutation in the erythroid-specific delta-aminolevulinate synthase gene (ALAS2) in the original family described by Cooley.
Cotter PD; Rucknagel DL; Bishop DF
Blood; 1994 Dec; 84(11):3915-24. PubMed ID: 7949148
[TBL] [Abstract][Full Text] [Related]
7. A novel mutation of the erythroid-specific gamma-Aminolevulinate synthase gene in a patient with non-inherited pyridoxine-responsive sideroblastic anemia.
Harigae H; Furuyama K; Kudo K; Hayashi N; Yamamoto M; Sassa S; Sasaki T
Am J Hematol; 1999 Oct; 62(2):112-4. PubMed ID: 10577279
[TBL] [Abstract][Full Text] [Related]
8. A promoter mutation in the erythroid-specific 5-aminolevulinate synthase (ALAS2) gene causes X-linked sideroblastic anemia.
Bekri S; May A; Cotter PD; Al-Sabah AI; Guo X; Masters GS; Bishop DF
Blood; 2003 Jul; 102(2):698-704. PubMed ID: 12663458
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminolevulinate synthase in sideroblastic anemias: mRNA and enzyme activity levels in bone marrow cells.
Bottomley SS; Healy HM; Brandenburg MA; May BK
Am J Hematol; 1992 Oct; 41(2):76-83. PubMed ID: 1415186
[TBL] [Abstract][Full Text] [Related]
10. Enzymatic defect in "X-linked" sideroblastic anemia: molecular evidence for erythroid delta-aminolevulinate synthase deficiency.
Cotter PD; Baumann M; Bishop DF
Proc Natl Acad Sci U S A; 1992 May; 89(9):4028-32. PubMed ID: 1570328
[TBL] [Abstract][Full Text] [Related]
11. R411C mutation of the ALAS2 gene encodes a pyridoxine-responsive enzyme with low activity.
Furuyama K; Uno R; Urabe A; Hayashi N; Fujita H; Kondo M; Sassa S; Yamamoto M
Br J Haematol; 1998 Dec; 103(3):839-41. PubMed ID: 9858242
[TBL] [Abstract][Full Text] [Related]
12. X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns.
Aivado M; Gattermann N; Rong A; Giagounidis AA; Prall WC; Czibere A; Hildebrandt B; Haas R; Bottomley SS
Blood Cells Mol Dis; 2006; 37(1):40-5. PubMed ID: 16735131
[TBL] [Abstract][Full Text] [Related]
13. Arg452 substitution of the erythroid-specific 5-aminolaevulinate synthase, a hot spot mutation in X-linked sideroblastic anaemia, does not itself affect enzyme activity.
Furuyama K; Harigae H; Heller T; Hamel BC; Minder EI; Shimizu T; Kuribara T; Blijlevens N; Shibahara S; Sassa S
Eur J Haematol; 2006 Jan; 76(1):33-41. PubMed ID: 16343269
[TBL] [Abstract][Full Text] [Related]
14. Animal models for X-linked sideroblastic anemia.
Yamamoto M; Nakajima O
Int J Hematol; 2000 Aug; 72(2):157-64. PubMed ID: 11039663
[TBL] [Abstract][Full Text] [Related]
15. Pyridoxine-responsive primary acquired sideroblastic anaemia. In vitro and in vivo effects of vitamin B6 on decreased 5-aminolaevulinate synthase activity.
Meier PJ; Fehr J; Meyer UA
Scand J Haematol; 1982 Nov; 29(5):421-4. PubMed ID: 7156891
[TBL] [Abstract][Full Text] [Related]
16. Multiple mechanisms for hereditary sideroblastic anemia.
Furuyama K; Sassa S
Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):5-10. PubMed ID: 11929048
[TBL] [Abstract][Full Text] [Related]
17. Pyridoxine refractory X-linked sideroblastic anemia caused by a point mutation in the erythroid 5-aminolevulinate synthase gene.
Furuyama K; Fujita H; Nagai T; Yomogida K; Munakata H; Kondo M; Kimura A; Kuramoto A; Hayashi N; Yamamoto M
Blood; 1997 Jul; 90(2):822-30. PubMed ID: 9226183
[TBL] [Abstract][Full Text] [Related]
18. Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia.
Bottomley SS; May BK; Cox TC; Cotter PD; Bishop DF
J Bioenerg Biomembr; 1995 Apr; 27(2):161-8. PubMed ID: 7592563
[TBL] [Abstract][Full Text] [Related]
19. Multiple enzymatic defects in mitochondria in hematological cells of patients with primary sideroblastic anemia.
Aoki Y
J Clin Invest; 1980 Jul; 66(1):43-9. PubMed ID: 6249845
[TBL] [Abstract][Full Text] [Related]
20. Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia.
Brownlie A; Donovan A; Pratt SJ; Paw BH; Oates AC; Brugnara C; Witkowska HE; Sassa S; Zon LI
Nat Genet; 1998 Nov; 20(3):244-50. PubMed ID: 9806542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
